Advanced Search

Home > Journals > > Archive > The Journal of Cardiovascular Surgery 2013 June;54(3) > The Journal of Cardiovascular Surgery 2013 June;54(3):333-6

CURRENT ISSUE   ARCHIVE   EPUB AHEAD OF PRINT   MOST READ   eTOC


The Journal of Cardiovascular Surgery 2013 June;54(3):333-6

INNOVATIONS IN DRUG-ELUTING TECHNOLOGY 

Femoropopliteal in-stent restenosis: review and potential for drug based therapy

Phillips J. 1, Ansel G. 2

1 Cardiology, Internal Medicine Ohio Health Riverside Methodist Hospital Columbus, OH, USA;
2 Cardiology, Internal Medicine Ohio Health Riverside Methodist Hospital Columbus, OH, USA

Endovascular treatment of symptomatic peripheral arterial disease in the femoropopliteal (FP) artery is fraught with high rates of restenosis. Success of the antiproliferative drug, paclitaxel, in the coronary arteries, has lead to the investigation of paclitaxel in the peripheral arteries to treat restenosis. This article reviews restenosis rates for the major treatment modalities used in the FP segment. Use of drug-elution for restenosis is also reviewed, including the use of drug-eluting balloons and drug-eluting stents.

language: English


FULL TEXT  REPRINTS

top of page